Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Schenkein David P Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Schenkein David P (Director) has filed a Form 4 on Prime Medicine, Inc.
Txns: Granted 39,062 options to buy @ $14.83, valued at $579.3k
06/05/2023 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 4,216 shares @ $0
Granted 12,649 options to buy @ $30.92, valued at $391.1k
04/05/2023 4 Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Sold 16,363 shares @ $22.85, valued at $373.9k
Exercised 16,363 options to buy @ $9.05, valued at $148.1k
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2023 4 Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Sold 18,333 shares @ $22.47, valued at $411.9k
Sold 1,667 shares @ $22.72, valued at $37.9k
Exercised 20,000 options to buy @ $9.05, valued at $181k
03/01/2023 4 Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Sold 20,000 shares @ $25.37, valued at $507.4k
Exercised 20,000 options to buy @ $9.05, valued at $181k
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2023 4 Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Sold 18,966 shares @ $28.82, valued at $546.6k
Sold 1,034 shares @ $29.49, valued at $30.5k
Exercised 20,000 options to buy @ $9.05, valued at $181k
10/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Paid exercise price by delivering 758 shares @ $29.08, valued at $22k
Exercised 2,775 restricted stock units @ $0
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2021 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Exercised 3,253 restricted stock units @ $0
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 25,000 shares @ $90.0622, valued at $2.3M
Sold 5,000 shares @ $90.0054, valued at $450k
11/13/2020 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 30,000 shares @ $70.053, valued at $2.1M
11/12/2020 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 10,000 shares @ $60.031, valued at $600.3k
11/06/2020 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Sold 10,000 shares @ $50.183, valued at $501.8k
06/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 15,183 options to buy @ $28.82, valued at $437.6k
Granted 3,253 restricted stock units @ $0
06/01/2020 4 Schenkein David P (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns: Granted 8,096 options to buy @ $53.35, valued at $431.9k
Granted 1,686 restricted stock units @ $0
02/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2019 4 Schenkein David P (Director) has filed a Form 4 on bluebird bio, Inc.
Txns: Granted 1,000 shares @ $0
Granted 4,000 options to buy @ $122.01, valued at $488k
06/03/2019 4 Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.
Txns: Granted 27,245 options to buy @ $19.5, valued at $531.3k
02/26/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/19/2018 4 Schenkein David P (CEO) has filed a Form 4 on AGIOS PHARMACEUTICALS INC
Txns: Gifted 1,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy